Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsFrench drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.